Physician profile
William C Lavely
NPI 1164449146
$86,978.00
in general payments reported to CMS, 2019-2025
10 companies · $63K in 2025
The $63K reported for 2025 was more than what 99% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $10K · 2021: $1,284 · 2022: $126 · 2024: $20.84 · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Honoraria: $6,720 · Travel and Lodging: $4,980 · Consulting Fee: $3,600 · Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,216.25 |
| Honoraria | $6,720.00 |
| Travel and Lodging | $4,979.71 |
| Consulting Fee | $3,600.00 |
| Food and Beverage | $708.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $59,696.34 | 2022-2025 | |
| Medivation LLC. | $18,520.00 | 2019-2020 | |
| Blue Earth Diagnostics | $4,740.67 | 2019-2021 | |
| Telix Pharmaceuticals | $3,600.00 | 2025 | Illuccix |
| Pfizer INC. | $210.00 | 2021 | |
| Advanced Accelerator Applications | $125.23 | 2019 | |
| Cardinal Health 414 LLC | $40.99 | 2019-2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Curium US LLC | $32.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.96 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lavely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.